Advertisement
BLK or BN or IVZ
Which Stock Would AI Choose? BlackRock (BLK) vs. Brookfield Corporation (BN) vs. Invesco (IVZ) Stock Comparison
Key Takeaways
- BlackRock (BLK) remains the world's largest asset manager, recently reporting record assets under management (AUM) of roughly $15.5 trillion and strong ETF-driven inflows.
- Brookfield Corporation (BN) is a diversified alternative asset manager and owner of operating businesses, leaning on infrastructure, real estate, and its growing insurance (wealth solutions) platform.
- Invesco (IVZ) is a smaller traditional asset manager whose recent results were lifted by the conversion of its flagship QQQ product to an exchange-traded fund (ETF) structure.
- The three companies operate at very different scales and with different business mixes, making this comparison a study in market positioning rather than a like-for-like contest.
- Relative performance and sentiment have diverged, with BlackRock benefiting from strong momentum while Invesco's near-term price action has softened.
Introduction
Investors evaluating financial and asset-management stocks often face a trade-off between scale, business diversification, and valuation. BLK, BN, and IVZ sit at three distinct points on that spectrum. BlackRock dominates global asset management, Brookfield blends asset management with direct ownership of real assets, and Invesco competes as a focused, mid-sized manager. This stock comparison is most relevant to investors weighing stability and momentum against diversification and valuation, particularly those following how capital flows, fee income, and market sentiment shape each business.
BLK Overview and Recent Performance
BlackRock (BLK) is the world's largest asset manager, with AUM surpassing $15 trillion and a product mix spanning equities, fixed income, multi-asset, cash, and alternatives. Its iShares ETF franchise remains a central growth engine, while technology services and a growing private-markets platform have expanded the firm's reach beyond traditional fund management.
Recent market activity has favored the stock. BlackRock reported strong quarterly results, with revenue up roughly 19% year over year, record net inflows, and an adjusted operating margin that widened toward 48%. Analysts responded by raising price targets, and at least one major firm upgraded the shares. Sentiment has been supported by consistent ETF inflows, improving profitability, and progress integrating recent acquisitions into its private-markets and technology businesses, though execution risk around deal integration remains a consideration.
BN Overview and Recent Performance
Brookfield Corporation (BN) is a global alternative investment firm whose structure combines three pillars: asset management, wealth solutions (insurance), and direct ownership of operating businesses in infrastructure, renewable power, real estate, and private equity. This diversified model distinguishes it from pure asset managers and ties results to both fee income and the cash flows of its own investments.
In recent quarters, Brookfield has emphasized simplifying its corporate structure and scaling its insurance platform, including completing an acquisition that meaningfully expanded its assets under management in that segment. Distributable earnings (a non-IFRS measure of cash available to shareholders) have grown steadily, supported by fee-bearing capital growth and resilient operating results. The company has also repurchased its own shares, signaling management's view that the stock trades below intrinsic value, even as near-term price momentum has been more muted than some peers.
IVZ Overview and Recent Performance
Invesco (IVZ) is a global investment manager with roughly $2.5 trillion in AUM, spanning ETFs, index products, active strategies, and private markets. A defining recent event has been the conversion of its flagship QQQ product into an open-end ETF, a structural change that altered how its fees and flows are reported and added a new revenue stream.
Recent results have shown higher revenues and AUM, with record long-term net inflows in the latest quarter and a meaningful improvement in adjusted operating margin. However, near-term price action has turned softer, with the stock declining over the past month even as longer-horizon returns remain strong. Sentiment is mixed: bulls point to improving margins and capital returns, while bears highlight ongoing outflows in certain active strategies and competitive fee pressure from lower-cost passive products.
Trending AI Robots
Tickeron's Trending AI Robots page curates a selection of the platform's best-performing AI trading bots for current market conditions. Tickeron offers hundreds of AI Trading Bots that collectively trade thousands of different tickers, but only a fraction earn a place in this featured section. These bots differ substantially in trading style, strategy, timeframe, performance statistics, and the specific tickers they trade, so the curation helps surface the approaches most aligned with today's market. Many featured bots display measurable performance metrics and win-rate statistics, allowing users to compare signals at a glance. Exploring the Trending AI Robots page can help investors identify which automated strategies are currently favored.
Head-to-Head Comparison
The three stocks diverge most sharply on business model and scale. BLK is a high-margin, asset-light franchise whose growth depends on flows, technology subscriptions, and expanding into private markets. BN is asset-heavy and diversified, blending recurring fee income with direct investment returns, making it more sensitive to credit conditions, property values, and the pace of asset monetizations. IVZ is the most traditional of the three, exposed to fee compression and product-rotation risk but also carrying a lower valuation and a more defensive dividend yield.
On recent momentum, BlackRock has shown the strongest trend consistency, while Invesco's gains have moderated and Brookfield's profile is steadier but less headline-driven. Risk profiles also differ: BlackRock and Invesco carry market and flow sensitivity, whereas Brookfield adds leverage and interest-rate exposure through its owned assets. For valuation-sensitive investors, Invesco trades at a lower multiple of earnings, while BlackRock commands a premium for scale and Brookfield sits between the two, valued partly on the discount to its own view of intrinsic value.
Tickeron AI Verdict
Based on observable factors, Tickeron's AI would most likely favor BLK in the current environment. BlackRock combines the most consistent recent trend, strong flow momentum, expanding margins, and clear near-term catalysts, all of which tend to score favorably in quantitative signal models. BN offers structural value and diversification but presents less clear short-term momentum, while IVZ shows improving fundamentals against softer recent price action. This is a probabilistic read rather than a definitive prediction, and relative positioning can shift quickly as market conditions evolve.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
BLK in upward trend: 10-day moving average broke above 50-day moving average on October 22, 2026
The 10-day moving average for BLK crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on BLK as a result. In 43 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.
The Moving Average Convergence Divergence (MACD) for BLK just turned positive on September 25, 2026. Looking at past instances where BLK's MACD turned positive, the stock continued to rise in 24 of 46 cases over the following month. The odds of a continued upward trend are 52%.
BLK moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where BLK advanced for three days, in 194 of 338 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
The Aroon Indicator entered an Uptrend today. In 143 of 293 cases where BLK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 49%.
Bearish Trend Analysis
The 10-day RSI Indicator for BLK moved out of overbought territory on October 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 19 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 53%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BLK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
BLK broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 29 (best 1 - 100 worst), indicating outstanding price growth. BLK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 47 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 49 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 63 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.057) is normal, around the industry mean (2.404). P/E Ratio (26.836) is within average values for comparable stocks, (-3.413). Projected Growth (PEG Ratio) (0.898) is also within normal values, averaging (1.319). Dividend Yield (0.020) settles around the average of (0.272) among similar stocks. P/S Ratio (6.270) is also within normal values, averaging (15.798).
BN's RSI Oscillator ascending out of oversold territory
The RSI Indicator for BN moved out of oversold territory on October 01, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In 20 of the 26 cases the stock moved higher. This puts the odds of a move higher at 77%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on BN as a result. In 59 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for BN just turned positive on September 29, 2026. Looking at past instances where BN's MACD turned positive, the stock continued to rise in 27 of 46 cases over the following month. The odds of a continued upward trend are 59%.
Following a +2.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where BN advanced for three days, in 225 of 340 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
BN broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BN entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 56 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 70 (best 1 - 100 worst), indicating slightly worse than average price growth. BN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.011) is normal, around the industry mean (2.404). P/E Ratio (68.357) is within average values for comparable stocks, (-3.413). Projected Growth (PEG Ratio) (0.110) is also within normal values, averaging (1.319). Dividend Yield (0.007) settles around the average of (0.272) among similar stocks. P/S Ratio (1.135) is also within normal values, averaging (15.798).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
IVZ's RSI Indicator climbs out of oversold territory
The RSI Indicator for IVZ moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In 28 of the 32 cases the stock moved higher. This puts the odds of a move higher at 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 56 cases where IVZ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
Following a +3.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where IVZ advanced for three days, in 227 of 334 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
IVZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IVZ as a result. In 59 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.
IVZ moved below its 50-day moving average on September 22, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for IVZ crossed bearishly below the 50-day moving average on September 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 76%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IVZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for IVZ entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. IVZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 53 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.276) is normal, around the industry mean (2.404). P/E Ratio (-42.970) is within average values for comparable stocks, (-3.413). Projected Growth (PEG Ratio) (0.901) is also within normal values, averaging (1.319). Dividend Yield (0.030) settles around the average of (0.272) among similar stocks. P/S Ratio (1.981) is also within normal values, averaging (15.798).
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
BLK | BN | IVZ | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 36 | 12 | 63 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | 83 Overvalued | 75 Overvalued | |
PROFIT vs RISK RATING 1..100 | 47 | 56 | 53 | |
SMR RATING 1..100 | 63 | 87 | 92 | |
PRICE GROWTH RATING 1..100 | 29 | 70 | 47 | |
P/E GROWTH RATING 1..100 | 49 | 92 | 99 | |
SEASONALITY SCORE 1..100 | 85 | 85 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IVZ's Valuation (75) in the Investment Managers industry is in the same range as BN (83) and is in the same range as BLK (90). This means that IVZ's stock grew similarly to BN’s and similarly to BLK’s over the last 12 months.
BLK's Profit vs Risk Rating (47) in the Investment Managers industry is in the same range as IVZ (53) and is in the same range as BN (56). This means that BLK's stock grew similarly to IVZ’s and similarly to BN’s over the last 12 months.
BLK's SMR Rating (63) in the Investment Managers industry is in the same range as BN (87) and is in the same range as IVZ (92). This means that BLK's stock grew similarly to BN’s and similarly to IVZ’s over the last 12 months.
BLK's Price Growth Rating (29) in the Investment Managers industry is in the same range as IVZ (47) and is somewhat better than the same rating for BN (70). This means that BLK's stock grew similarly to IVZ’s and somewhat faster than BN’s over the last 12 months.
BLK's P/E Growth Rating (49) in the Investment Managers industry is somewhat better than the same rating for BN (92) and is somewhat better than the same rating for IVZ (99). This means that BLK's stock grew somewhat faster than BN’s and somewhat faster than IVZ’s over the last 12 months.
| BLK | BN | IVZ | |
|---|---|---|---|
| RSI ODDS (%) | 2 days ago 53% | 2 days ago 77% | 2 days ago 88% |
| Stochastic ODDS (%) | 2 days ago 60% | 2 days ago 60% | 2 days ago 79% |
| Momentum ODDS (%) | 2 days ago 57% | 2 days ago 74% | 2 days ago 71% |
| MACD ODDS (%) | 2 days ago 52% | 2 days ago 59% | N/A |
| TrendWeek ODDS (%) | 2 days ago 64% | 2 days ago 67% | 2 days ago 70% |
| TrendMonth ODDS (%) | 2 days ago 60% | 2 days ago 61% | 2 days ago 69% |
| Advances ODDS (%) | 3 days ago 57% | 2 days ago 66% | 3 days ago 68% |
| Declines ODDS (%) | 16 days ago 56% | 5 days ago 67% | 10 days ago 70% |
| BollingerBands ODDS (%) | 2 days ago 50% | 2 days ago 57% | 2 days ago 79% |
| Aroon ODDS (%) | 2 days ago 49% | 2 days ago 55% | 2 days ago 62% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BLK’s FA Score shows that 1 FA rating(s) are green while BN’s FA Score has 0 green FA rating(s), and IVZ’s FA Score reflects 0 green FA rating(s).
- BLK’s FA Score: 1 green, 4 red.
- BN’s FA Score: 0 green, 5 red.
- IVZ’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BLK’s TA Score shows that 6 TA indicator(s) are bullish while BN’s TA Score has 4 bullish TA indicator(s), and IVZ’s TA Score reflects 4 bullish TA indicator(s).
- BLK’s TA Score: 6 bullish, 4 bearish.
- BN’s TA Score: 4 bullish, 4 bearish.
- IVZ’s TA Score: 4 bullish, 5 bearish.
Price Growth
BLK (@Investment Managers) experienced а +1.47% price change this week, while BN (@Investment Managers) price change was +3.99% , and IVZ (@Investment Managers) price fluctuated -0.03% for the same time period.
The average weekly price growth across all stocks in the @Investment Managers industry was -0.67%. For the same industry, the average monthly price growth was -6.40%, and the average quarterly price growth was -2.19%.
Reported Earning Dates
BLK is expected to report earnings on Jan 21, 2027.
BN is expected to report earnings on Nov 12, 2026.
IVZ is expected to report earnings on Oct 27, 2026.
Industries' Descriptions
@Investment Managers (-0.67% weekly)Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
Advertisement
BN and
Correlation & Price change
A.I.dvisor indicates that over the last year, BN has been closely correlated with BAM. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if BN jumps, then BAM could also see price increases.
IVZ and
Correlation & Price change
A.I.dvisor indicates that over the last year, IVZ has been closely correlated with BLK. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if IVZ jumps, then BLK could also see price increases.